Knoll Capital Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $177 Million distributed in 39 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Aldeyra Therapeutics, Inc. with a value of $28.3M, Biohaven Pharmaceutical Holding CO Ltd. with a value of $13.4M, Spdr Gold Trust with a value of $11.4M, Entera Bio Ltd. with a value of $11.2M, and Meira G Tx Holdings PLC with a value of $10.3M.
Examining the 13F form we can see an increase of $30.1M in the current position value, from $147M to 177M.
Knoll Capital Management, LLC is based out at Miami, FL
Below you can find more details about Knoll Capital Management, LLC portfolio as well as his latest detailed transactions.